Ingalls & Snyder’s Innospec IOSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.76M Hold
28,927
– – 0.07% 141
2026
Q2
$2.35M Hold
28,927
– – 0.06% 153
2026
Q1
$2.11M Hold
28,927
– – 0.07% 149
2025
Q4
$2.21M Hold
28,927
– – 0.08% 154
2025
Q3
$2.23M Hold
28,927
– – 0.07% 156
2025
Q2
$2.43M Hold
28,927
– – 0.09% 148
2025
Q1
$2.74M Buy
28,927
+59
+0.2% +$6.24K 0.09% 130
2024
Q4
$3.18M Hold
28,868
– – 0.12% 111
2024
Q3
$3.26M Buy
28,868
+272
+1% +$31.7K 0.13% 114
2024
Q2
$3.53M Buy
+28,596
New +$3.58M 0.15% 105

Other funds holding IOSP

Ingalls & Snyder's IOSP Position: Q3 2026 in Review

Ingalls & Snyder held its Innospec (IOSP) position steady in Q3 2026 at 28,927 shares worth $2.76M. The position accounts for 0.07% of the portfolio, ranked #141.

Ingalls & Snyder first reported a position in IOSP in Q2 2024 and has held it in 10 quarters since. The position peaked at $3.53M in Q2 2024. 227 funds tracked by Wall St. Rank hold IOSP as of Q3 2026.

  • Ingalls & Snyder held 28,927 shares of Innospec worth $2.76M as of Q3 2026.
  • Ingalls & Snyder left its Innospec share count unchanged in Q3 2026.
  • Innospec made up 0.07% of Ingalls & Snyder's portfolio in Q3 2026, its #141 holding.
  • Ingalls & Snyder first reported a position in Innospec in Q2 2024 and has held it in 10 quarters since.
  • Ingalls & Snyder's Innospec position peaked at $3.53M in Q2 2024.
  • 227 funds tracked by Wall St. Rank held Innospec as of Q3 2026.

Based on Ingalls & Snyder's 13F filing for Q3 2026, filed 12 Nov 2026.